Patti’s research is focused in the rapidly evolving field of metabolomics. He is developing new mass spectrometry and nuclear magnetic resonance (NMR) technologies.
In the media
Gary J. Patti in Arts & Sciences and the School of Medicine and Kristen M. Patti at the School of Medicine write about how collaboration between diverse groups with different perspectives promotes scientific discovery. To enhance these partnerships and facilitate communication, innovative advances in universal design are essential.
Gary Patti, the Michael and Tana Powell Professor of Chemistry in Arts & Sciences at Washington University in St. Louis, has been awarded $4.8 million in two separate National Institutes of Health (NIH) grants focused on improving the accessibility of metabolomics — the study of the biochemical reactions that underlie metabolism.
Gary Patti has been named the Michael and Tana Powell Associate Professor of Chemistry at Washington University in St. Louis. He was installed Dec. 1 in a ceremony in the Laboratory Sciences building.
Scientists at Washington University estimate that the number of metabolites present in a data set could be 90 percent smaller than previously estimated.
For more than 80 years, scientists have thought that cancer cells fuel their explosive growth by soaking up glucose from the blood, using its energy and atoms to crank out duplicate sets of cellular components. But is this really true? Work in a metabolomics laboratory at Washington University in St. Louis suggests not.
The Alfred P. Sloan Foundation announced Feb. 17 that Washington University in St. Louis’ Gary Patti has been awarded a 2014 Sloan Research Fellowship. He is among 126 outstanding U.S. and Canadian researchers selected as fellowship recipients this year. Awarded annually since 1955, the fellowships are given to early-career scientists and scholars whose achievements and potential identify them as rising stars, the next generation of scientific leaders.
Investigators at Washington University and The Scripps Research Institute have announced the launch of a “Global Metabolomic Initiative” to facilitate meta-analyses on studies of the metabolism of bacteria, yeast, plants, animals and people. Although metabolomics has existed as a discipline for only a decade, it has already provided insights into many difficult-to-treat diseases, including chronic pain. Many more are expected to fall out of the meta-analyses.